Announcements

Showing items 3211 - 3220 of 4242 stories.

Protecting coal miners from black lung disease

In a report published by the National Academies of Sciences, Engineering and Medicine, WVU School of Public Health researcher Michael McCawley and his colleagues pinpoint shortcomings in how miners’ exposure to respirable coal-mine dust is monitored. Inhaling this dust over time leads to black lung disease.

West Virginia University Rockefeller Neuroscience Institute pioneers promising new Alzheimer’s therapy

Investigators at the West Virginia University Rockefeller Neuroscience Institute performed the first procedure in the world of a phase II trial using focused ultrasound to treat a patient with early stage Alzheimer’s. The procedure took place yesterday, and the blood brain barrier was opened successfully; the patient was sent home earlier today. Led by neurosurgeon Ali Rezai, MD, the WVU team tested this innovative treatment in collaboration with INSIGHTEC, an Israeli medical technology company. Earlier this year, INSIGHTEC was approved by the U.S. Food and Drug Administration to begin a phase II clinical trial of the procedure, and selected the WVU Rockefeller Neuroscience Institute as the first site in the United States for the trial.

PBS series to feature WVU faculty

James Berry, DO, associate professor of behavioral medicine and psychiatry, and Mark Smith, MD, clinical faculty in the Department of Pediatrics, will be featured in an upcoming episode of PBS's NOVA series.

James Berry joins webinar on opioid use disorder, recovery

James Berry, DO, associate professor of behavioral medicine and psychiatry, recently participated in a webinar on addiction, "Opioid Use Disorder in Special Populations: Making Recovery a Goal." Participants may recieve CE credit if they are: